Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BASF presents small molecules with tyrosine kinase-inhibitory activity

Nov. 16, 2000

Acronycine analogue S-23906 confirmed as a potential development candidate for solid tumors

Nov. 16, 2000

Promising phase III results with Gliadel as first-line treatment of malignant glioma

Nov. 16, 2000

Verteporfin shows promise in clinical trials for the treatment of skin cancer

Nov. 16, 2000

Licensing opportunity from NIH: vaccinia virus vector for cancer therapy

Nov. 16, 2000

Pfizer prepares series of 2-pyridinylguanidine urokinase inhibitors

Nov. 15, 2000

Two series of styryl sulfone antitumor agents reported recently by U.S. university researchers

Nov. 15, 2000

New pure antiestrogen with promising activity in breast cancer discovered at Schering

Nov. 15, 2000

Vascular targeting agent for cancer therapy profiled at NCI-EORTC-AACR symposium

Nov. 15, 2000

Irreversible EGF receptor kinase inhibitor EKB-569 advanced to phase I trials in cancer patients

Nov. 15, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...